Financials data is unavailable for this security.
Cash flow in CADView more
In 2023, MustGrow Biologics Corp did not generate a significant amount of cash. Cash Flow from Financing totalled 95.75k or 2.03% of revenues. In addition the company used 294.76k for operations while cash used for investing totalled .
Cash flow per share | -0.0083 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0726 |
---|---|
Tangible book value per share | 0.0726 |
More ▼
Balance sheet in CADView more
Current ratio | 4.87 |
---|---|
Quick ratio | 4.84 |
Total debt/total equity | 0.1383 |
---|---|
Total debt/total capital | 0.1215 |
More ▼